Profitability Ratios
| Ratio |
Value |
| GP Margin |
67.3% |
| EBIT Margin |
10.3% |
| EBITDA Margin |
18.6% |
| Operating Margin |
10.3% |
| Pretax Margin |
4.5% |
| Cont. Ops Margin |
4.8% |
| Net Margin |
4.0% |
| Bottom Line Margin |
4.0% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.70 |
| Quick Ratio |
1.19 |
| Solvency Ratio |
0.153 |
| Cash Ratio |
0.32 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.13 |
| Forward PEG |
-0.13 |
| Price/Book |
2.69 |
| Price/Sales |
0.87 |
| Price/FCF |
6.94 |
| Price/Op Cash Flow |
6.70 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.4555 |
| Debt/Equity |
1.6911 |
| Debt/Capital |
0.6284 |
| Long-Term Debt/Capital |
0.6024 |
| Financial Leverage |
3.71 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
6.39 |
| Operating Cash Flow Ratio |
0.461 |
| Operating Cash Flow/Sales |
13.0% |
| Free Cash Flow/Operating Cash Flow |
96.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.34 |
| Interest Coverage |
2.2105 |
| Short-Term Operating Cash Flow Coverage |
3.85 |
| Operating Cash Flow Coverage |
0.24 |
| Capital Expenditure Coverage |
28.87 |
| Dividend + Capital Expenditure Coverage |
28.87 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
8.53 |
| EPS |
0.341 |
| Debt/Share |
5.0708 |
| Cash/Share |
0.77 |
| Book Value/Share |
3.43 |
| Tangible BV/Share |
-2.21 |
| Equity/Share |
2.76 |
| Operating Cash Flow/Share |
1.110 |
| Capital Expenditure/Share |
0.038 |
| FCF/Share |
1.072 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.884 |
| Earnings Before Tax/EBIT |
0.439 |
| Price/Fair Value |
2.69 |
| Debt/Market Cap |
0.6015 |
| Effective Tax Rate |
-6.1% |
| Enterprise Value Multiple |
7.16 |
BVS - Bioventus Inc.